Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Introduction
00:00 • 2min
Anti-Quagulation Reversal
02:09 • 2min
The Inherent Inar Effect of F F Por or Vitam in K So Kinnow
03:39 • 2min
What's the History of PC C Products?
05:12 • 2min
Is There a Life Threatening Need for Pc C Products?
07:27 • 2min
Is Ff P the Most Appropriate Option?
09:35 • 3min
Is Fixed Dose Ccentra Dosing for Orporin Reversal?
12:41 • 2min
Is the Fixed Dose a Good Idea?
14:16 • 3min
Dose C Centra
17:01 • 2min
Is Your Management Changed for Patients With an Ion Ar Less Than Two?
18:51 • 2min
Cacentra vs Poeba
21:14 • 2min
Dosing Strategies for Doax Reversal
22:48 • 4min
Hemorrhage Efficacy - Is That a Good Number?
26:56 • 3min
C Centra vs Poeba for Doac Reversal?
30:02 • 3min
Casentra in Piba on Hospital Formularies?
32:35 • 2min
Do You Think the Doax Is a Good Reversal Agent?
34:18 • 2min
Do You Think We'd Be Using Indexa More?
36:28 • 3min
Is the Am Index a Reversal Agent?
39:25 • 2min
Dosing Maintenance Infusions
41:05 • 4min
Dosage for Warfon Reversal?
45:14 • 3min
Podcast - The Side of Mashed Potatoes and Gravy
47:54 • 3min